Hemodialysis is one among the three renal replacement therapies used for extracorporeal separation of waste components from blood in case of kidney failure. Hemodialysis access, also known as vascular access is a way to access blood for hemodialysis, which can be achieved by three different ways, a fistula, a graft, and a catheter. Hemodialysis access graft are U-shaped plastic tube used for hemodialysis, which connects arteries and veins under the skin of the patient’s arms.
Hemodialysis access graft are used in patients with blocked or damaged veins in which fistula cannot be used. However, hemodialysis access graft do not last as long as fistula, which is expected to be the major factor that is expected to hamper hemodialysis access graft market growth. Moreover, factors that are expected to drive growth of the market include increasing product approvals and rising incidence of chronic kidney disorders. For instance, according to Centers for Disease Control and Prevention (CDC) 2017 factsheet, 30 million people, which comprises 15% of the U.S. adults were estimated to suffer from chronic kidney disease.
Get an exclusive sample copy of the business report: https://www.coherentmarketinsights.com/insight/request-sample/1840
Hemodialysis Access Graft Market Dynamics
Novel product launches by market players is a major factor that is expected to fuel growth of the hemodialysis access graft market over the forecast period. For instance, in 2013, CryoLife, Inc. received the CE mark for the HeRO Graft for patients with failing fistulas or blocked veins leading to heart. The company claims HeRO graft as only fully subcutaneous AV access solution. In 2013, Gore & Associates launched Gore Acuseal vascular graft for vascular access. Key feature of Gore Acuseal vascular graft such as it provides early cannulation, which is within 24 hours of post-implantation, owing to its trilayer design with low-bleed elastomeric membrane sandwiched between two expanded polytetrafluoroethylene layers. Various companies are focused on adopting trilayer design to sustain in the hemodialysis access graft market. Thus, it is expected to offer growth opportunities for emerging and new entrants in the market.
Increasing incidence of end stage renal disease and other kidney related disorders are major factors that are expected to drive growth of the hemodialysis access graft market. According to Centers for Disease Control and Prevention (CDC) factsheet 2017, in 2014, the number of people underwent treatment for end stage renal diseases were 118,000 in the U.S. and 662,000 survived on chronic dialysis or with kidney transplant. According to University of California, 2013, end stage renal disease is increasing by 5% per year in the U.S. In 2013, according to the Renal Association UK Renal Registry, around 57,000 adults in the U.K. were on treatment for kidney failure, of which 42% received hemodialysis.
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 25% OFF On Any Research Report
Apply Promo Code “CHRISTMAS2020” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1840
Hemodialysis Access Graft Market – Regional Analysis
Regional segmentation of hemodialysis access graft market by Coherent Market Insights include North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America hemodialysis access graft market is expected to hold a dominant position in the market over the forecast period. This is attributed to high prevalence of kidney failure in the region. For instance, according to the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK), 2015, in the U.S., around 661,000 U.S. population suffered from kidney failure, of which 468,000 individuals were on dialysis. However, Asia Pacific hemodialysis access graft market is expected to witness fastest growth due to large patient pool suffering from diabetes, which increases risk of renal failure. For instance, according to the World Health Organization (WHO) 2017 bulletin, South East Asian population is exhibiting drastic increase in prevalence of diabetes. For instance, the prevalence of diabetes was 46,903,000 in year 2000, which is expected to reach 119,541,000 by 2030. This is expected to create a conducive environment for growth of the market in the region.
Hemodialysis Access Graft Market – Competitive Analysis
Key players operating in the global hemodialysis access graft market include W.L. Gore & Associated, C. R. Bard, Merit Medical Systems, Inc., and Getinge Group.
Companies are focusing on acquiring complementary business or products to strengthen their market position. For instance, in 2016, Merit Medical Systems, Inc., a manufacturer and marketer of proprietary disposable medical devices used for interventional and diagnostic procedures acquired HeRO Graft and its related assets from Cryolife, Inc. for US$ 18.5 million. Furthermore, in 2011, Atrium Medical was acquired by Getinge Group for US$ 680 million. The acquisition of Atrium is a strategic move by Getinge Group to leverage scientific and technological advances of both the companies and company will also get access to vascular grafts of Atrium Medical.
To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/hemodialysis-access-graft-market-1840
Hemodialysis Access Graft Market Taxonomy
Based on material:
- Biological Grafts
- Synthetic Grafts
- Biosynthetic Grafts
Based on end-user:
- Hospitals
- Dialysis centers
- Ambulatory Surgical Centers
- Clinics
- Home Care Settings
Based on the region:
- North America
- Europe
- Latin America
- Asia Pacific
- Middle East
- Africa
Other Exclusive Reports:
NEPHROLOGY AND UROLOGY DEVICES MARKET ANALYSIS
CONTINUOUS RENAL REPLACEMENT THERAPY MARKET ANALYSIS
VASCULAR GRAFTS MARKET ANALYSIS
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
